UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chylöser Aszites bei NSCLC: Nicht alles ist maligne, was maligne aussieht

Pneumologie (Stuttgart, Germany), 2023-04, Vol.77 (12), p.1013-1015

2023

Volltextzugriff (PDF)

Asiatic acid induces lung cancer toxicity by triggering SRC-mediated ferroptosis

Toxicology and applied pharmacology, 2024-11, Vol.492, p.117097, Article 117097

2024

Volltextzugriff (PDF)

Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

Molecular & cellular proteomics, 2024-08, p.100834, Article 100834

2024

Volltextzugriff (PDF)

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

Oncoimmunology, 2017-06, Vol.6 (6), p.e1320011-e1320011

2017

Volltextzugriff (PDF)

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Oncotarget, 2018-01, Vol.9 (4), p.4637-4646

2018

Volltextzugriff (PDF)

Deep learning-assisted interactive contouring of lung cancer: Impact on contouring time and consistency

Radiotherapy and oncology, 2024-11, Vol.200, p.110500, Article 110500

2024

Volltextzugriff (PDF)

Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors

European journal of medicinal chemistry, 2024-12, Vol.279, p.116858, Article 116858

2024

Volltextzugriff (PDF)

Micro RNA-148a Targets Bcl-2 in Patients with Non-Small Cell Lung Cancer

Asian Pacific Journal of Cancer Prevention, 2021-06, Vol.22 (6), p.1949-1955

2021

Volltextzugriff (PDF)

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Journal of experimental & clinical cancer research, 2017-12, Vol.36 (1), Article 174

2017

Volltextzugriff (PDF)

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Cancer, 2018-01, Vol.124 (2), p.271-277

2018

Volltextzugriff (PDF)

Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway

Molecular immunology, 2017-10, Vol.90, p.197-210

2017

Volltextzugriff (PDF)

Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer

Chest, 2018-12, Vol.154 (6), p.1416-1423

2018

Volltextzugriff (PDF)

Poly(2-(dimethylamino) ethyl methacrylate)-b-poly (hydroxy propyl methacrylate) nanoparticles for guided delivery of MCL-1 CRISPR-Cas9 plasmid and doxorubicin to non-small cell lung cancer

European polymer journal, 2024-10, Vol.219, p.113408, Article 113408

2024

Volltextzugriff (PDF)

EGFR signaling pathway as therapeutic target in human cancers

Seminars in cancer biology, 2022-10, Vol.85, p.253-275

2022

Volltextzugriff (PDF)

Regulator of G protein signaling 20 contributes to radioresistance of non-small cell lung cancer cells by suppressing pyroptosis

Radiation medicine and protection, 2024-09, Vol.5 (3), p.178-184

2024

Volltextzugriff (PDF)

The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC

Journal of thoracic oncology, 2019-08, Vol.14 (8), p.1378-1389

2019

Volltextzugriff (PDF)

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1501-1511

2021

Volltextzugriff (PDF)

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.867-875

2019

Volltextzugriff (PDF)

Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated at Phramongkutklao Hospital between 2011 and 2018: Comparison between Those With and Without Brain Metastases

Journal of the Medical Association of Thailand, 2021-12, Vol.104 (12), p.1888-1894

2021

Volltextzugriff (PDF)

In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56

Asian Pacific Journal of Cancer Prevention, 2020-08, Vol.21 (8), p.2297-2306

Herrera, Leana Rich M

2020

Volltextzugriff (PDF)

Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab

Journal of thoracic oncology, 2018-11, Vol.13 (11), p.1771-1775

2018

Volltextzugriff (PDF)

Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial

Annals of oncology, 2023-10, Vol.34 (10), p.907-919

2023

Volltextzugriff (PDF)

Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway

Pharmacological research, 2019-12, Vol.150, p.104504, Article 104504

2019

Volltextzugriff (PDF)

Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis

Academic radiology, 2024-04

2024

Volltextzugriff (PDF)

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Annals of oncology, 2022-10, Vol.33 (10), p.1029-1040

2022

Volltextzugriff (PDF)

26 – 50 von 15.121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12.592)
Mit Volltextzugriff
(13.597)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(13.128)
Life Sciences & Biomedicine
(12.917)
Nsclc
(10.247)
Oncology
(8.105)
Humans
(7.351)
Lung Cancer
(5.141)
Lung Neoplasms - Pathology
(3.687)
Female
(3.391)
Non-Small Cell Lung Cancer
(3.367)
Carcinoma, Non-Small-Cell Lung - Pathology
(3.357)
Male
(3.330)
Lung Neoplasms - Drug Therapy
(3.171)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3.119)
Respiratory System
(2.877)
Middle Aged
(2.837)
Aged
(2.665)
Lung Neoplasms - Genetics
(2.629)
Carcinoma, Non-Small-Cell Lung - Genetics
(2.574)
Non-Small Cell Lung Carcinoma
(2.536)
Tumors
(2.209)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(9.382)
Ingenta
(7.542)
MEDLINE
(7.436)
IngentaConnect Journals
(4.538)
Journals@Ovid
(3.921)
Elsevier ScienceDirect Journals Complete
(3.025)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.193)
SpringerLink
(1.921)
Wiley Online Library
(1.237)
Access via Taylor & Francis
(1.197)
Publisher or Other Site
(940)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(910)
Taylor & Francis
(785)
Wiley Online Library
(578)
Taylor & Francis Online
(515)
SAGE Journals
(344)
Nexis Uni
(305)
Ebook Central Perpetual and DDA
(175)
eBooks on EBSCOhost
(169)
Nature_系列刊
(160)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(835)
Translational Lung Cancer Research
(565)
Journal Of Thoracic Disease
(501)
Journal Of Thoracic Oncology
(471)
Frontiers In Oncology
(444)
Clinical Lung Cancer
(373)
Cancers
(364)
Oncotarget
(295)
Anticancer Research
(196)
Thoracic Cancer
(194)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Chylöser Aszites bei NSCLC: Nicht alles ist maligne, was maligne aussieht

Asiatic acid induces lung cancer toxicity by triggering SRC-mediated ferroptosis

Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Deep learning-assisted interactive contouring of lung cancer: Impact on contouring time and consistency

Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors

Micro RNA-148a Targets Bcl-2 in Patients with Non-Small Cell Lung Cancer

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway

Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer

Poly(2-(dimethylamino) ethyl methacrylate)-b-poly (hydroxy propyl methacrylate) nanoparticles for guided delivery of MCL-1 CRISPR-Cas9 plasmid and doxorubicin to non-small cell lung cancer

EGFR signaling pathway as therapeutic target in human cancers

Regulator of G protein signaling 20 contributes to radioresistance of non-small cell lung cancer cells by suppressing pyroptosis

The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated at Phramongkutklao Hospital between 2011 and 2018: Comparison between Those With and Without Brain Metastases

In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56

Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab

Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial

Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway

Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Suchergebnisse filtern